Neurological Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030

Neurological Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030

Neurological Biomarker Trends and Forecast

The future of the global neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets. The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030 with a CAGR of 11.7% from 2024 to 2030. The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Neurological Biomarker by Segment

The study includes a forecast for the global neurological biomarker by type, application, end use, and region.

Neurological Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Genomic
• Proteomic
• Metabolomic
• Imaging
• Others

Neurological Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Alzheimer’S Disease
• Parkinson’S Disease
• Multiple Sclerosis
• Autism Spectrum Disorder
• Others

Neurological Biomarker Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospital & Hospital Laboratories
• Independent Clinical Diagnostic Centers
• Research Organizations and Others

Neurological Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Neurological Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurological biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurological biomarker companies profiled in this report include-

• Abbott
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Merck
• Johnson & Johnson Services
• Banyan Biomarkers
• Myriad Genetics

Neurological Biomarker Market Insights

Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.

Within this market, hospitals and hospital laboratories will witness the highest growth as they are considered as a primary providers of diagnostic services for neurological disorders.

North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.

Features of the Global Neurological Biomarker Market

Market Size Estimates: Neurological biomarker market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neurological biomarker market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Neurological biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the neurological biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurological biomarker market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the neurological biomarker market size?

Answer: The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030.

Q.2 What is the growth forecast for neurological biomarker market?

Answer: The global neurological biomarker market is expected to grow with a CAGR of 11.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the neurological biomarker market?

Answer: The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.

Q4. What are the major segments for neurological biomarker market?

Answer: The future of the neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets.

Q5. Who are the key neurological biomarker market companies?

Answer: Some of the key neurological biomarker companies are as follows:

• Abbott
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Merck
• Johnson & Johnson Services
• Banyan Biomarkers
• Myriad Genetics

Q6. Which neurological biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.

Q7. In neurological biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the neurological biomarker market by type (genomic, proteomic, metabolomic, imaging, and others), application (alzheimer’s disease, parkinson’s disease, multiple sclerosis, autism spectrum disorder, and others), end use (hospital & hospital laboratories, independent clinical diagnostic centers, and research organizations and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.